In order to analyse the use and to improve our websites and to inform you about our company on other websites, we would like to use cookies. If you agree, please click “Accept”. If you would like to select individually which cookies we can use, to amend your settings or to receive more detailed information, go to “More information". Cookie information More information Accept PRESS CONTACT GLOBAL SITES Please select Search Information for... Please select Value through Innovation At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. OUR FOCUS articulates who we are and what we strive for, how we work and what we want to achieve. BI at BIO Europe 2021 card image Connect With Us Boehringer Ingelheim at BIO Europe 2021 Click through to our virtual BIO Europe ‘Hub’ and find out more about partnering with us and how we’re working with the life-science community to be first4patients. Read more on Boehringer Ingelheim at BIO Europe 2021 Pause Previous 1 2 3 4 5 Next Explore Our Content PRESS RELEASE 11 Nov 2021 at 17:30 Boehringer Ingelheim launches Boehringer Ingelheim Social Engagements Sustainable health solutions for 50 million people PRESS RELEASE 11 Nov 2021 at 12:00 Making More Health Together 2021: Creating sustainable health solutions for 50 million people in vulnerable communities Franc and Anne DIABETES Conversations Beyond Type 2 Diabetes To mark World Diabetes Day, Anne and Franc, who are living with T2D, explore what it means to live with their condition. More Potential PRESS RELEASE 03 Nov 2021 at 16:00 Boehringer Ingelheim increases commitments to sustainable development, to impact 50 million people through social innovation Moore Green PRESS RELEASE 01 Nov 2021 at 10:00 Boehringer Ingelheim shares updated 2030 environmental sustainability commitments Man with poultry in stable POULTRY Action makes the difference in poultry farms Farmers, be on the lookout to protect chickens against the ILT virus! Automated tablet factory opens in Ingelheim PRESS RELEASE 27 Oct 2021 at 16:15 Boehringer Ingelheim opens high-tech tablet production facility in Ingelheim There are microbes in the picture as well as a pill box, and arrows go from one to the other in a circular motion OUR RESPONSIBILITY Antimicrobial resistance: a growing concern Antimicrobial resistance is a major global threat to the health of humans and animals alike. Learn about challenges and solutions here. Home:Homepage About Us Corporate Profile Careers Press Global Activities Science Human Health Animal Health Digital Health Human Pharma Cardiovascular Oncology Respiratory Central Nervous System Metabolic Diseases Immunology Retinal Health Business Units Prescription Medicine Animal Health Biopharma Global Activities Africa Asia Australasia Europe North America South America Share Back To Top Accessibility Statement Terms of Use Data Privacy Imprint © 2010-2021 Boehringer Ingelheim International GmbH. All rights reserved.